Drug intelligence / Profile preview

NSC105808

Development stage
Preclinical
Lead developer
National Cancer Institute
Modality
Small Molecules
Administration
Parenteral
01

Overview

NSC105808 is a small molecule research compound identified as a specific inhibitor of the DNA2 nuclease/helicase. DNA2 is a multifunctional enzyme that plays a critical role in maintaining genomic stability through its involvement in DNA replication (specifically Okazaki fragment maturation) and various DNA repair pathways, including double-strand break repair and the recovery of stalled replication forks. By specifically targeting the nuclease activity of DNA2, NSC105808 disrupts these essential genomic maintenance processes, leading to increased replication stress, DNA damage accumulation, and apoptosis in cancer cells. Preclinical studies have demonstrated that NSC105808 possesses potent antitumor activity and can sensitize cancer cells to other DNA-damaging agents, making it a valuable chemical probe for studying DNA2 biology and a potential lead for cancer therapeutic development.

02

Targets

DNA2 (DNA replication helicase/nuclease 2)

Beyond the preview

Go deeper on NSC105808.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NSC105808.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call